M. Wilt

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Thierry Petit, M. Wilt, Michel Velten et al. · European Journal of Cancer · 2003 · 273 citations

Medicine, Oncology, Pharmacology +17

Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial

Jean-François Rodier, Michel Velten, M. Wilt et al. · Journal of Clinical Oncology · 2007 · 127 citations · Full text

Medicine, Oncology, Breast Oncology +16

Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction

Femke J. Amelung, Wernard A. A. Borstlap, Esther C. J. Consten et al. · British journal of surgery · 2019 · 106 citations · Full text

Medicine, Oncology, Surgery +16

Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer

Thierry Petit, M. Wilt, Michel Velten et al. · Breast Cancer Research and Treatment · 2010 · 33 citations · Full text

Medicine, Oncology, Breast Oncology +15

Anal localization as first manifestation of metastatic ductal breast carcinoma

R Haberstich, Jean‐Jacques Tuech, M. Wilt et al. · Techniques in Coloproctology · 2005 · 31 citations

Medicine, Oncology, Pathology +12